JPMorgan Chase’s Jiangsu Hengrui H-Share Position Falls to 9.74%
HKEX says JPMorgan Chase’s long position in Jiangsu Hengrui Pharma H-shares decreased to 9.74% on Oct. 22.
Related stories
High Quality Food reports Q3 2026 revenue of €4.6 million
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
X-FAB Silicon Foundries Reports Third-Quarter Revenue of $194.4 Million
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
Pilgrim’s Pride Q3 Profit Falls
M impact | EQUITY | Oct 29, 2026, 04:42 PM UTC
NX Filtration Launches Private Share Placement of Up to EUR 20 Million
NX Filtration launched a private share placement of up to EUR 20 million.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC
X-FAB Q3 Operating Profit Falls 82% Year Over Year
X-FAB reported Q3 2026 operating profit down 82% year over year.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC
C & I Leasing Reports Q3 Gross Earnings of 12.95 Billion Naira
The company reported Q3 profit from continuing operations before tax of 983.5 million naira.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC